AKT1 and neoplasm: Nuclear factor kappa B inhibitor could be degraded by upstream phosphorylation of Akt, allowing NF‐кB released from the cytoplasm to translocate to the nucleus and act on target genes, which all considered as the important regulatory pathways in tumour proliferation and metastasis.